#GemPharmatech will be attending the 2023 BioPacific Conference, also known as the #CABS (Chinese American #Biopharmaceutical Society) 24ᵗʰ Annual Conference, on October 28ᵗʰ, 2023! Come and connect with us at 𝐛𝐨𝐨𝐭𝐡 #𝟒𝟕!  We look forward to seeing you! #CABS2023 #Bio

Dr. Mark Moore, former Director of the International Mouse Phenotyping Consortium (IMPC), brings years of experience in biomedical research and drug development using animal models to GemPharmatech businesswire.com/news/home/2021…

GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio_GemPharmatech en.gempharmatech.com/content/detail…

Moving from Discovery to Clinic with Genetically Engineered Mouse Models_GemPharmatech en.gempharmatech.com/content/detail…

🔬 Discover the Future of Healthcare with Gempharmatech! 💊 🌟 We're revolutionizing the world of pharmaceuticals with cutting-edge technology and innovation. 💡 Explore our services and unlock the potential of tomorrow's medicine today 👉 en.gempharmatech.com/index.html #preclinical

A recent research explored the complex network of #immune cells and signals involved in the formation of granulomas in response to #Mycobacterium infections. sciencedirect.com/science/articl…

GemPharmatech's one-stop preclinical solution to accelerate your preclinical pipelines. Models available: 1. Humanized checkpoint models. 2. Immune deficient models. 3. Human immune system reconstituted models. 4. Spontaneous tumor models 5. Bispecific Antibody Evaluation. ----

N2B-patch Project n2b-patch.eu